Integrity Life Sciences announced it has submitted an application for an additional 510(k) clearance from the U.S. Food and Drug Administration for the newest version of the Integrity Spinal Care System.
Integrity Life Sciences was initially issued FDA clearance for the Integrity Spinal Care System — a non-surgical medical device that applies therapeutic distraction forces to a patient's spinal column to alleviate low back and neck pain for numerous spinal disorders. The newest version of the system will directly and exclusively target the low back region or lumbar spine.
More Articles on Devices:
Is Biomet Next to Form IPO?
Bioventus Names VP of Global Marketing
Aurora Spine Appoints New VP of Sales